Globe Editorial
IN THE five years between 1998 and 2003, research grants by the National Institutes of Health doubled, fueling breakthrough work on the human genome and treatments for many diseases. Progress stalled after that, however, as Congress responded to the deficits caused by tax cuts and wars in Afghanistan and Iraq by flat lining the institutes' budget. On an inflation-adjusted basis, ... (Full article: 440 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





